AS

Abdul Salam Makrayil Pulluvan Valappil

Director Additional Director DIN 08615065
DIN 08615065 First appointment Nov 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Nov 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdul Salam Makrayil Pulluvan Valappil

Data last updated:

Abdul Salam Makrayil Pulluvan Valappil was an Additional Director at Indoerwin Pharmaceuticals Private Limited (2019–2020). The company operates in Chemicals.

DIN 08615065
Primary Designation Additional Director
Industry Chemicals
First Appointment 19 Nov 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director19 Nov 20192019₹37,047 (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indoerwin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abdul Salam Makrayil Pulluvan Valappil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Salam Makrayil Pulluvan Valappil

Abdul Salam Makrayil Pulluvan Valappil was first appointed on 19 Nov 2019 as Additional Director at Indoerwin Pharmaceuticals Private Limited.

Abdul Salam Makrayil Pulluvan Valappil held 1 earlier board appointment: Indoerwin Pharmaceuticals Private Limited (Additional Director, 19 Nov 2019 to 31 Dec 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available